Skip to main content

Abstract

Acne vulgaris is a chronic inflammatory skin disease mainly affecting adolescents and young adults. When evaluating the acne patient, the questions arise of whether laboratory evaluations are justified for acne vulgaris either in terms of diagnosis, monitoring during treatment, or for a hormonal work-up. This chapter addresses these questions aiming to provide available scientific data regarding laboratory evaluations for acne.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne Group. J Am Acad Dermatol. 2009;60:s1–50.

    Article  PubMed  Google Scholar 

  2. Antoniou C, Dessinioti C, Stratigos AJ, Katsambas A. Clinical and therapeutic approach in childhood acne: an update. Pediatr Dermatol. 2009;26:373–80.

    Article  CAS  PubMed  Google Scholar 

  3. Darley CR, Moore JW, Besser GM, et al. Androgen status in women with late onset or persistent acne vulgaris. Clin Exp Dermatol. 1984;9:28–35.

    Article  CAS  PubMed  Google Scholar 

  4. Lucky AW, McGuire J, Rosenfield RL, et al. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983;81:70–4.

    Article  CAS  PubMed  Google Scholar 

  5. Mathur RS, Moody LO, Landgrebe S, et al. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute females. Fertil Steril. 1981;35:296–305.

    Google Scholar 

  6. Schiavone FE, Rietschel RL, Sgoutas D, et al. Elevated free testosterone levels in women with acne. Arch Dermatol. 1983;119:799–802.

    Article  CAS  PubMed  Google Scholar 

  7. Scholl GM, Wu CH, Leyden J. Androgen excess in women with acne. Obstet Gynecol. 1984;64:683–8.

    CAS  PubMed  Google Scholar 

  8. Carmina E, Lobo RA. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Endocrinol Metab. 1993;76:1111–4.

    CAS  PubMed  Google Scholar 

  9. Odlind V, Carlstrom K, Michaelsson C, et al. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty. Clin Endrocrinol. 1982;16:243–9.

    Article  CAS  Google Scholar 

  10. Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28:17–23.

    Article  PubMed  Google Scholar 

  11. Caputo V, Fiorella S, Curiale S, et al. Refractory acne and 21-hydroxylase deficiency in a selected group of female patients. Dermatology. 2010;220:121–7.

    Article  CAS  PubMed  Google Scholar 

  12. Placzek M, Arnold B, Schmidt H, et al. Elevated 17-hydroxyprogesterone serum values in male patients with acne. J Am Acad Dermatol. 2005;53:955–8.

    Article  PubMed  Google Scholar 

  13. Dessinioti C, Katsambas A. Congenital adrenal hyperplasia. Dermatoendocrinology. 2009;1:86–90.

    Article  Google Scholar 

  14. Chen W, Obermayer-Pietsch B, Hong JB, et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol. 2011;25:637–46.

    Article  CAS  PubMed  Google Scholar 

  15. Bunker CB, Newton JA, Kilborn J, et al. Most women with acne have polycystic ovaries. Br J Dermatol. 1989;121:675–80.

    Article  CAS  PubMed  Google Scholar 

  16. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:671–83.

    Article  PubMed  Google Scholar 

  17. Gollnick H, Cunliffe W, Berson D, et al. Management of acne. J Am Acad Dermatol. 2003;49:S20–25.

    Article  Google Scholar 

  18. Katsambas A, Dessinioti C. New and emerging treatments in dermatology: acne. Dermatol Ther. 2008;21:86–95.

    Article  CAS  PubMed  Google Scholar 

  19. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology. 2000;200:223–31.

    Article  CAS  PubMed  Google Scholar 

  20. Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol. 2007;157:540–6.

    Article  CAS  PubMed  Google Scholar 

  21. Schaffer JV, Davidson DM, McNiff JM, et al. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol. 2001;44:198–206.

    Article  CAS  PubMed  Google Scholar 

  22. Gait RC, Affleck AG, Leach IH, et al. Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol. 2008;58(5 suppl 1):s123–4.

    Article  PubMed  Google Scholar 

  23. Akin E, Miller LC, Tucker LB. Minocycline-induced lupusin adolescents. Pediatrics. 1998;101:926–8.

    Article  CAS  PubMed  Google Scholar 

  24. Elkayam O, Levartovsky D, Brautbar C, et al. Clinical and immunologic study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med. 1998;105:484–7.

    Article  CAS  PubMed  Google Scholar 

  25. Dunphy J, Oliver M, Rands AL, et al. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol. 2000;142:461–7.

    Article  CAS  PubMed  Google Scholar 

  26. Shapiro LE, Uetrecht J, Shear NH. Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol. 2001;45:787–9.

    Article  CAS  PubMed  Google Scholar 

  27. Katsambas A, Papakonstantinou A. Acne: systemic treatment. Clin Dermatol. 2004;22:412–8.

    Article  PubMed  Google Scholar 

  28. Friedman SJ. Leukopenia and neutropenia is associated with isotretinoin therapy. Arch Dermatol. 1987;123:293–5.

    Article  CAS  PubMed  Google Scholar 

  29. Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacutter. 2003;37:1622–4.

    Article  Google Scholar 

  30. Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J Dermatol Treat. 2001;12:9–12.

    Article  CAS  Google Scholar 

  31. Warren KJ, Cruz PD. Clinical outcome and cost analysis of isotretinoin versus conventional regiments in the treatment of moderate acne vulgaris in male patients. Pediatr Dermatol. 1998;15:329–31.

    Article  CAS  PubMed  Google Scholar 

  32. Altman RS, Altman LJ. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgatis. Dermatology. 2002;204:232–5.

    Article  CAS  PubMed  Google Scholar 

  33. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol. 1994;131:360–3.

    Article  CAS  PubMed  Google Scholar 

  34. Lebucher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology. 1993;186:123–8.

    Article  Google Scholar 

  35. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris. Ten years later. A safe and successful treatment. Br J Dermatol. 1993;129:292–6.

    Article  CAS  PubMed  Google Scholar 

  36. Stainforth JM, Layton AM, Taylor JP, et al. Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol. 1993;129:297–301.

    Article  CAS  PubMed  Google Scholar 

  37. Lester RS, Schachter GD, Light MJ. Isotretionin and tetracycline in the management of severe nodulocystic acne. Int J Dermatol. 1985;24:252–7.

    Article  CAS  PubMed  Google Scholar 

  38. Cunliffe WJ, van der Kerkhof PC, Caputo R, et al. Roaccutane: treatment guidelines: results of international survey. Dermatology. 1997;194:351–7.

    Article  CAS  PubMed  Google Scholar 

  39. Ortonne JP. Oral isotretinoin treatment policy: do we all agree? Dermatology. 1997;195 Suppl 1:34–7. discussion 38–40.

    Article  PubMed  Google Scholar 

  40. Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin? J Dermatol Treat. 2006;17:214–6.

    Article  CAS  Google Scholar 

  41. Baxter KF, Ling TC, Barth JH, et al. Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoin. J Dermatol Treat. 2003;14:216–8.

    Article  CAS  Google Scholar 

  42. Johnson TM, Rapini RP. Isotretinoin-induced thrombocytopenia. J Am Acad Dermatol. 1987;17:838–9.

    Article  CAS  PubMed  Google Scholar 

  43. Michaelsson G, Vahlquist A, Mobacken H, et al. Changes in laboratory variables induced by isotretinoin treatment of acne. Acta Derm Venereol. 1986;66:144–8.

    CAS  PubMed  Google Scholar 

  44. Zane LT, Leyden WA, Marqueling AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142:1016–22.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clio Dessinioti .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dessinioti, C., Zouboulis, C.C. (2014). Laboratory Evaluations in Acne. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_50

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics